Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease
about
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor featuresNetwork neighbors of drug targets contribute to drug side-effect similarityPriority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease
P2860
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@ast
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@en
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@en-gb
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@nl
type
label
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@ast
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@en
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@en-gb
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@nl
prefLabel
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@ast
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@en
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@en-gb
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@nl
P2860
P1476
Catechol-O-methyltransferase i ...... cations in Parkinson's disease
@en
P2093
Sybille Spieker
P2860
P356
10.1002/14651858.CD004553.PUB2
P577
2004-10-18T00:00:00Z